We're lifting our price target on Cardinal Health after issuing rosy profit guidance

We're lifting our price target on Cardinal Health after issuing rosy profit guidance Skip Navigation Markets Pre-Markets U.S. Markets Currencies Prediction Markets Cryptocurrency Futures & Commodities Bonds Funds & ETFs Business Economy Finance Health & Science Media Real Estate Energy Climate Transportation Investigations Industrials Retail Wealth Sports Life Small Business Investing Personal Finance Fintech Financial Advisors Options Action ETF Street Buffett Archive Earnings Trader Talk Tech Cybersecurity AI Enterprise Internet Media Mobile Social Media CNBC Disruptor 50 Tech Guide Politics & Policy White House Policy Defense Congress Expanding Opportunity Video Latest Video Full Episodes Livestream Live Audio Live TV Schedule CNBC Podcasts CEO Interviews CNBC Documentaries Digital Originals Watchlist Investing Club Trust Portfolio Analysis Trade Alerts Meeting Videos Homestretch Jim's Columns Education Subscribe PRO Pro News Josh Brown Mike Santoli Calls of the Day My Portfolio Livestream Full Episodes Stock Screener Market Forecast Options Investing Chart Investing Subscribe Livestream Menu Make It select USA INTL Livestream Search quotes, news & videos Livestream Watchlist SIGN IN Create free account Markets Business Investing Tech Politics & Policy Video Watchlist Investing Club PRO Livestream Menu We're lifting our price target on Cardinal Health after issuing rosy profit guidance Published Tue, Aug 11 2026 3:58 PM EDT Updated 3 Min Ago Zev Fima @zevfima Cardinal Health on Tuesday showed why the healthcare distributor belongs in our portfolio, delivering robust full-year earnings guidance that trumped some imperfections in the final quarter of its fiscal 2026. Revenue for the three months ending June 30 increased nearly 6% year over year to $63.67 billion, missing expectations of $65.03 billion, according to LSEG. Adjusted earnings per share (EPS) came in at $2.60, ahead of the $2.42 consensus estimate compiled by LSEG. The 18-cent earnings beat excludes a 31-cent per share benefit from tariff refunds paid by the U.S. Shares of Cardinal Health are up about 1% in afternoon trading to roughly $240 apiece. Bu özet bilgilendirme amaçlıdır, yatırım tavsiyesi değildir. — hisseonlinebot